Loading clinical trials...
Loading clinical trials...
Vyndaqel Capsules Special Investigation - Investigation on Patients With Transthyretin Amyloid Cardiomyopathy
Conditions
Interventions
Treatment for TTR amyloidosis
Treatment for TTR amyloidosis
Locations
1
Japan
Pfizer
Tokyo, Japan
Start Date
October 3, 2019
Primary Completion Date
March 27, 2025
Completion Date
March 27, 2025
Last Updated
May 8, 2025
NCT07196839
NCT01994889
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions